Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects

doi:10.3389/fmicb.2018.02888

Chia Nan University of Pharmacy & Science Institutional Repository > 藥理學院 > 保健營養系(所) > 期刊論文 > Item 310902800/32320

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/32320

標題:	Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects
作者:	Jean, Shio-Shin Lee, Nan-Yao Tang, Hung-Jen Lu, Min-Chi Ko, Wen-Chien Hsueh, Po-Ren
貢獻者:	Taipei Med Univ, Dept Emergency, Sch Med, Coll Med Taipei Med Univ, Dept Emergency Med, Wan Fang Hosp Taipei Med Univ, Dept Emergency & Crit Care Med, Wan Fang Hosp Natl Cheng Kung Univ, Dept Internal Med, Med Coll & Hosp Chi Mei Med Ctr, Dept Med Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr China Med Univ, Dept Microbiol & Immunol, Sch Med Natl Taiwan Univ, Dept Lab Med, Natl Taiwan Univ Hosp, Coll Med Natl Taiwan Univ, Dept Internal Med, Natl Taiwan Univ Hosp, Coll Med
關鍵字:	carbapenem-resistant Enterobacteriaceae carbapenemase Klebsiella pneumoniae Escherichia coli long-term care facility tigecycline colistin avibactam
日期:	2018-11-27
上傳時間:	2019-12-16 09:35:31 (UTC+8)
出版者:	FRONTIERS MEDIA SA
摘要:	Carbapenem-resistant Enterobacteriaceae (CRE), a major resistance concern emerging during the last decade because of significantly compromising the efficacy of carbapenem agents, has currently become an important focus of infection control. Many investigations have shown a high association of CRE infections with high case-fatality rates. In Taiwan, a few surveys observed that a significant proportion (29-47%) of the CR-Klebsiella pneumoniae isolates harbored a plasmidic allele encoding K. pneumoniae carbapenemases (KPC, especially KPC-2). A significant increase in the number of oxacillinase (OXA)-48-like carbapenemases among CR-K. pneumoniae isolates was observed between 2012 and 2015. By striking contrast, isolates of CR-Escherichia coli and CR-Enterobacter species in Taiwan had a much lower percentage of carbapenemase production than CR-K. pneumoniae isolates. This differs from isolates found in China as well as in the India subcontinent. Apart from the hospital setting, CRE was also cultured from the inpatients from communities or long-term care facilities (LTCF). Therefore, implementation of regular CRE screening of LTCF residents, strict disinfectant use in nursing homes and hospital settings, and appropriate control of antibiotic prescriptions is suggested to alleviate the spread of clinical CRE isolates in Taiwan. Although there are some promising new antibiotics against CRE, such as ceftazidime-avibactam, meropenem-vaborbactam, aztreonam-avibactam and cefiderocol, these agents are not available in Taiwan currently. Therefore, in order to effectively decrease case-fatality rates among patients with the infections owing to carbapenemase-producing CRE isolates, combination antibiotic schemes, including colistin (or amikacin) and/or tigecycline in combination with an anti-pseudomonal carbapenem agent, remain the mainstay for treating clinical CRE infections.
link:	http://dx.doi.org/10.3389/fmicb.2018.02888
關聯:	Nova Hedwigia, v.9, 2888
显示于类别:	[保健營養系(所) ] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
10.3389-fmicb.2018.02888.pdf		492Kb	Adobe PDF	416	检视/开启
index.html		0Kb	HTML	1242	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....